Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

TransCode Therapeutics, Inc. - Common Stock (NQ: RNAZ )

8.940 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,827,661
Open 8.940
Bid (Size) 9.800 (1)
Ask (Size) 9.970 (2)
Prev. Close 8.940
Today's Range 8.940 - 8.940
52wk Range 2.660 - 66.33
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Here are the top movers in Wednesday's session.
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
What's going on in today's session
Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes. 
Via Chartmill

Performance

YTD
+153.26%
+153.26%
1 Month
+156.16%
+156.16%
3 Month
-42.24%
-42.24%
6 Month
+7.08%
+7.08%
1 Year
-56.16%
-56.16%

More News

Read More
The trading volume of these stocks is deviating from the norm in today's session.
Via Chartmill
How Is The Market Feeling About TransCode Therapeutics?
Via Benzinga
Peering Into TransCode Therapeutics's Recent Short Interest
Via Benzinga
Why TransCode Therapeutics (RNAZ) Stock Is Diving
Via Benzinga
Why Transcode Therapeutics (RNAZ) Stock Is Moving
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Top movers analysis one hour before the close of the markets on 2025-01-28: top gainers and losers in today's session.
Via Chartmill
Unusual volume stocks are being observed in Tuesday's session.
Via Chartmill
These stocks are moving in today's session
Via Chartmill
The market is filled with gapping stocks in Tuesday's session.
Via Chartmill
On Friday, there are stocks with unusual volume. Let's take a look.
Via Chartmill
TransCode Therapeutics Shares Are Surging Today: What's Going On?
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Crude Oil Gains Over 1%, General Mills Shares Fall
Via Benzinga
Exposures Fossil Fuels
Dow Surges 150 Points, US Current Account Deficit Widens In Q3
Via Benzinga
Topics Stocks
Exposures US Equities
TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split
From TransCode Therapeutics, Inc.
Via GlobeNewswire
TransCode Therapeutics, Inc. Announces $8 Million Private Placement
From TransCode Therapeutics, Inc.
Via GlobeNewswire
TransCode Therapeutics Announces 1-for-33 Reverse Stock Split
From TransCode Therapeutics, Inc.
Via GlobeNewswire
TransCode Therapeutics Open Letter to Shareholders
From TransCode Therapeutics, Inc.
Via GlobeNewswire
TransCode Therapeutics Announces Nasdaq Extension to Regain Compliance
From TransCode Therapeutics, Inc.
Via GlobeNewswire
TransCode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 TTX-MC138 Clinical Trial Following Favorable Review of Cohort 1 Safety Data
From TransCode Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
TransCode Therapeutics Completes Initial Dosing of First Cohort in Phase 1 Clinical Trial with TTX-MC138, a microRNA-Targeted Technology
From TransCode Therapeutics, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.